Next, we constructed a gene expression signature comprising of six genes, MROH8, BET1, PTPRN2, STC1, NKX3-1, and ARMC10, which was strongly associated with the clinical characteristics of GBM and had good prognosis accuracy in both TCGA and the CGGA datasets. This evidence concerns the gene ARMC10 and glioblastoma.